As part of an ongoing effort to expand precision medicine access to their patients and employees, Baptist Health has extended its partnership with its Genomic Decision Support vendor, ActX, until 2028.
LOUISVILLE, Ky., April 13, 2023 /PRNewswire-PRWeb/ -- As part of an ongoing effort to expand precision medicine access to their patients and employees, Baptist Health has extended its partnership with its Genomic Decision Support vendor, ActX, until 2028.
At Baptist Health, ActX is integrated into the EpicCare electronic health record, providing actionable genomic decision support at the point of care, allowing Baptist Health providers to make better decisions about medical treatment using patient's genetic information. Baptist has utilized the service at its nine owned hospitals and more than 400 points of care over the past several years.
In 2022 Baptist Health launched a pilot program to study the benefits of genetic testing with a sample group of its employees. Comparing 2022 claims data to 2020 and 2021, the results showed fewer claims and an average cost savings of $482 per study patient per month, for a total savings of $2.6 million so far. In 2023, Baptist Health included coverage for pharmacogenetic testing to all employees and dependents enrolled in their medical plan.
"Over the past several years ActX has helped Baptist Health make the best therapeutic choices for many patients by personalizing their medical care with genetics" said Brett Oliver, MD, Chief Medical Information Officer at Baptist Health.
"With the extension of the Baptist Health-ActX partnership, we will be able to further expand this important initiative, increasing our capabilities by enabling precision medicine for many more individuals".
"We are excited to help expand the important work Baptist Health is doing with precision medicine." said Andrew Ury, MD, CEO of ActX. "Baptist Health has been a leader in showing the important benefits of an EHR integrated genomic decision support model".
About ActX
ActX helps physicians make better decisions about medical treatment, using patients' genetic information. ActX uses its GenoACT℠ clinical decision support program to analyze a patient's genetic information and alert physicians in real time through their existing workflow tools about drug-genome interactions, actionable hereditary risks and carrier status. For more information, visit http://www.actx.com, email [email protected] or call 888-998-2289.
About Baptist Health
Founded in 1924 in Louisville, Kentucky, Baptist Health is a full-spectrum health system dedicated to improving the health of the communities it serves. The Baptist Health family consists of nine hospitals, employed and independent physicians, and more than 400 points of care, including outpatient facilities, physician practices and services, urgent care clinics, outpatient diagnostic and surgery centers, home care, fitness centers, and occupational medicine and physical therapy clinics.
Baptist Health's eight owned hospitals include more than 2,300 licensed beds in Corbin, Elizabethtown, LaGrange, Lexington, Louisville, Paducah, Richmond and New Albany, Indiana. Baptist Health also operates the 410-bed Baptist Health Deaconess Madisonville in Madisonville, Kentucky in a joint venture with Deaconess Health System based in Evansville, Indiana. Baptist Health employs more than 23,000 people in Kentucky and surrounding states.
Baptist Health is the first health system in the U.S. to have all of its hospitals recognized by the American Nursing Credentialing Center with either a Magnet® or Pathway to Excellence® designation for nursing excellence.
Baptist Health's employed provider network, Baptist Health Medical Group, has nearly 1,500 providers, including more than 750 physicians and more than 740 advanced practice clinicians. Baptist Health's physician network also includes more than 2,000 independent physicians.
Media Contact
Joe Sichel, ActX, 1 888-998-2289, [email protected]
SOURCE ActX
Share this article